Royal Biologics Unveils FDA-Approved Fibrinet® PRF Wound Matrix for Effective Wound Management Royal Biologics has announced FDA clearance for Fibrinet® PRF Wound Matrix, a groundbreaking technology for treating various cutaneous wounds, enhancing healing.

Royal Biologics Unveils FDA-Approved Fibrinet® PRF Wound Matrix for Effective Wound Management #United_States #Hackensack #Wound_Care #Royal_Biologics #Fibrinet_PRF